Zenotech Laboratories Ltd banner
Z

Zenotech Laboratories Ltd
BSE:532039

Watchlist Manager
Zenotech Laboratories Ltd
BSE:532039
Watchlist
Price: 45.32 INR 0.09%
Market Cap: ₹2.8B

Balance Sheet

Balance Sheet Decomposition
Zenotech Laboratories Ltd

Balance Sheet
Zenotech Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2002 Mar-2003 Mar-2004 Mar-2005 Mar-2006 Mar-2007 Mar-2008 Mar-2009 Mar-2010 Mar-2011 Mar-2012 Mar-2013 Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
1
0
125
36
24
2
2
14
13
4
5
4
64
4
3
5
284
132
11
25
24
111
18
266
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
6
25
24
0
18
6
Cash Equivalents
1
0
125
36
24
2
2
14
13
4
5
4
64
4
3
5
284
130
5
0
0
111
0
260
Short-Term Investments
0
0
0
0
0
21
602
312
150
0
0
12
0
0
0
0
0
0
0
1
2
0
179
1
Total Receivables
21
21
41
61
90
143
89
49
48
8
2
2
2
0
5
1
4
53
44
46
43
40
55
90
Accounts Receivables
21
21
25
32
49
95
19
6
17
0
0
0
1
0
3
0
0
25
19
38
39
33
37
78
Other Receivables
0
1
16
29
41
49
70
43
31
8
2
2
1
0
1
1
4
28
25
8
3
7
18
12
Inventory
0
0
4
14
24
52
55
29
23
8
3
22
39
0
16
9
8
6
1
1
1
0
9
1
Other Current Assets
0
0
0
0
0
1
8
17
20
52
16
6
4
0
2
3
18
1
1
1
4
11
2
2
Total Current Assets
21
21
170
111
137
220
756
422
255
72
26
46
108
0
25
18
314
192
57
73
74
163
262
360
PP&E Net
0
0
23
135
537
683
718
846
823
655
621
589
563
0
482
468
468
601
778
764
712
704
675
644
PP&E Gross
0
0
23
135
537
683
718
846
823
655
621
589
0
0
0
0
0
601
778
764
712
0
675
644
Accumulated Depreciation
0
0
1
3
8
27
59
90
118
160
195
228
0
0
0
0
0
159
208
272
342
0
485
554
Goodwill
0
0
0
0
16
16
16
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
0
0
0
0
37
36
31
0
0
0
3
18
13
12
24
34
45
51
Long-Term Investments
5
5
5
14
0
0
0
0
0
0
0
0
0
0
0
0
4
6
6
7
7
13
0
0
Other Long-Term Assets
7
7
87
127
147
159
284
448
561
890
0
0
0
0
22
21
28
29
2
2
124
95
80
55
Other Assets
0
0
0
0
16
16
16
10
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
34
N/A
34
N/A
285
+748%
388
+36%
837
+116%
1 077
+29%
1 774
+65%
1 726
-3%
1 649
-4%
1 617
-2%
684
-58%
670
-2%
702
+5%
0
N/A
529
N/A
507
-4%
817
+61%
846
+3%
856
+1%
858
+0%
941
+10%
1 009
+7%
1 062
+5%
1 110
+5%
Liabilities
Accounts Payable
0
0
6
13
77
72
40
37
21
22
24
43
33
0
43
51
54
41
46
19
21
35
28
25
Accrued Liabilities
0
0
0
1
4
7
8
3
2
0
5
11
0
0
0
0
0
30
28
29
31
0
2
31
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
20
130
438
0
512
512
0
202
187
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
32
31
0
31
31
31
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
1
4
14
21
21
13
17
53
85
188
193
0
402
570
340
179
94
101
104
131
105
70
Total Current Liabilities
0
0
7
18
95
100
69
53
40
75
165
403
664
31
988
1 164
394
453
354
149
156
166
135
126
Long-Term Debt
0
0
8
64
314
355
187
163
88
33
1
2
1
0
0
0
0
0
0
207
60
0
0
0
Deferred Income Tax
0
0
1
4
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
12
6
13
0
2
5
5
0
2
2
3
3
5
18
19
20
21
23
Total Liabilities
0
N/A
0
N/A
16
+15 800%
86
+440%
415
+384%
455
+10%
268
-41%
222
-17%
141
-37%
108
-23%
168
+56%
409
+143%
669
+64%
0
N/A
990
N/A
1 167
+18%
397
-66%
457
+15%
359
-21%
374
+4%
234
-37%
186
-21%
157
-16%
149
-5%
Equity
Common Stock
23
23
146
154
268
288
344
344
344
344
344
344
344
0
344
344
610
610
610
610
610
610
610
610
Retained Earnings
10
10
10
10
0
0
0
0
0
0
992
1 248
312
0
805
1 003
190
2 317
2 209
2 222
1 999
212
1 800
1 744
Additional Paid In Capital
0
0
112
138
153
334
1 160
1 164
1 165
1 164
1 164
1 164
0
0
0
0
0
2 095
2 095
2 095
2 095
0
2 095
2 095
Other Equity
0
0
0
0
1
1
3
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
34
N/A
34
N/A
269
+703%
302
+12%
422
+40%
622
+48%
1 506
+142%
1 504
0%
1 508
+0%
1 509
+0%
516
-66%
261
-49%
33
-88%
0
N/A
461
N/A
659
-43%
420
N/A
389
-7%
496
+28%
484
-2%
706
+46%
823
+16%
905
+10%
961
+6%
Total Liabilities & Equity
34
N/A
34
N/A
285
+748%
388
+36%
837
+116%
1 077
+29%
1 774
+65%
1 726
-3%
1 649
-4%
1 617
-2%
684
-58%
670
-2%
702
+5%
0
N/A
529
N/A
507
-4%
817
+61%
846
+3%
856
+1%
858
+0%
941
+10%
1 009
+7%
1 062
+5%
1 110
+5%
Shares Outstanding
Common Shares Outstanding
22
22
22
22
22
30
36
36
36
36
36
36
36
0
36
36
61
61
61
61
61
61
61
61
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett